Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs coverage and medical necessity determinations for dermatoscopy and computer-based optical imaging devices used to evaluate or serially monitor pigmented skin lesions suspicious for malignancy for Blue Cross Blue Shield - Rhode Island members.
No material clinical or coverage changes in this revision.
Coverage Criteria
Medicare Advantage - Not Covered
The following services are not covered for Medicare Advantage Plans when used to evaluate or serially monitor pigmented skin lesions:
Evidence is insufficient to determine the effects of the technology on health outcomes; limited photography for documentation is part of record keeping and not separately reimbursed.
Evidence is insufficient to determine the effects of the technology on health outcomes; limited photography for documentation is part of record keeping and not separately reimbursed.
Evidence is insufficient to determine the effects of the technology on health outcomes; FDA‑approved multispectral devices are intended for use by trained dermatologists, but evidence for improved health outcomes is insufficient.
Commercial - Not Medically Necessary
The following services are considered not medically necessary for Commercial Products when used to evaluate or serially monitor pigmented skin lesions:
Evidence is insufficient to determine the effects of the technology on health outcomes; limited photography for documentation is part of record keeping and not separately reimbursed.
Evidence is insufficient to determine the effects of the technology on health outcomes; limited photography for documentation is part of record keeping and not separately reimbursed.
Evidence is insufficient to determine the effects of the technology on health outcomes; diagnostic accuracy studies exist but no studies demonstrate improved patient management or outcomes.
Limited photography performed solely for documentation of skin findings is considered part of the medical record and is not separately reimbursed. This policy treats such limited clinical photography as record keeping rather than a billable service.
The excerpt does not list additional explicit coverage or exclusion rules beyond those stated here. Coverage and payment determinations are governed by the member's subscriber or employer agreement and by medical necessity determinations for the specific member; providers should verify benefits and eligibility with the provider call center for member-specific guidance.
For Commercial Products, dermatoscopy (including direct inspection, digitization of images, or computer-assisted analysis) and computer-based optical imaging devices (eg, multispectral digital skin lesion analysis) are considered not medically necessary when used to evaluate or serially monitor pigmented skin lesions. In addition, CPT code 96904 (whole body integumentary photography) is listed as not medically necessary / not covered in this context, and there is no specific CPT for computer-based optical imaging devices (claims for those devices should be filed with unlisted CPT 96999).
Services that are determined to be not medically necessary or that are identified as non-covered benefits under the member's coverage may be denied for payment. Providers may not charge the member for such denied or non-covered services unless the member was informed and provided written agreement in advance to accept financial responsibility.
Coding
| 96904 | Whole body integumentary photography, for monitoring of high risk patients with dysplastic nevus syndrome or a history of dysplastic nevi, or patients with a personal or familial history of melanoma |
| 96999 | Unlisted special dermatological service or procedure (recommended for computer-based optical imaging devices) |
Provider Actions and Billing Guidance
Prior authorization: Not applicable
Prior authorization is not required for the services addressed in this policy.
Verify member agreement for benefits & eligibility
Benefits and eligibility are determined by the member's subscriber certificate or employer agreement; check member-specific coverage before providing services.
- For member-specific benefits, call the provider call center.
- Member and employer agreements supersede this medical policy.
No step-therapy or prior authorization steps specified
Prior authorization field in the source is blank; no specific step-therapy or prior auth steps are defined in this policy excerpt.
No additional provider action noted
This policy excerpt contains no additional provider action notes beyond those addressing member agreements and general policy statements in the references section.
Limited photography is part of record keeping — not separately reimbursed
Limited photography used for documentation of skin lesions is considered part of the medical record and is not separately reimbursed.
Verify benefits and provider participation before billing
For member-specific benefits and eligibility, providers must contact the provider call center; participation agreements govern whether services may be charged to members.
- Refer to the member's subscriber agreement or employer agreement to determine coverage.
- Check participation agreement provisions for billing obligations to the member.
Denial risk: Dermatoscopy and related CPT codes
Claims for dermatoscopy or computer-based optical imaging devices are considered not covered (Medicare Advantage) or not medically necessary (Commercial). CPT 96904 (whole body photography) is listed as not covered/not medically necessary; computer-based device claims should be filed with unlisted CPT 96999.
Member agreement determines coverage; written consent required to bill member for non-covered services
Coverage and payment are determined by the member's subscriber or employer agreement; services determined to be not medically necessary (or non-covered benefits) may be denied and cannot be charged to the member unless the member was informed and agreed in writing in advance.
- Do not charge the member for non-covered or not medically necessary services unless the member provided prior written agreement.
- Member/employer agreements supersede this medical policy for coverage determinations.
Background
Dermatoscopy (also called dermoscopy) is a noninvasive visual technique that enables in vivo microscopic examination of pigmented skin lesions to help distinguish benign from malignant lesions. The method can include direct inspection with magnification, image digitization for storage or serial comparison, and computer-assisted analysis; FDA‑cleared multispectral devices use multiple wavelengths and proprietary algorithms to classify lesions as positive or negative for recommending biopsy.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.